Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $5,546 | 353 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $1,699 | 115 | $0 (2024) |
| Novo Nordisk Inc | $796.48 | 47 | $0 (2024) |
| Takeda Pharmaceuticals U.S.A., Inc. | $538.05 | 27 | $0 (2024) |
| Lilly USA, LLC | $529.83 | 38 | $0 (2024) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $273.34 | 20 | $0 (2024) |
| GlaxoSmithKline, LLC. | $264.96 | 16 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $258.00 | 15 | $0 (2024) |
| Abbott Laboratories | $158.39 | 10 | $0 (2024) |
| Biohaven Pharmaceuticals, Inc. | $120.46 | 9 | $0 (2021) |
| PFIZER INC. | $119.06 | 7 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,652 | 94 | ABBVIE INC. ($467.15) |
| 2023 | $1,387 | 88 | ABBVIE INC. ($376.46) |
| 2022 | $1,316 | 92 | ABBVIE INC. ($473.63) |
| 2021 | $1,191 | 79 | AbbVie Inc. ($382.01) |
All Payment Transactions
353 individual payment records from CMS Open Payments — Page 1 of 15
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/09/2024 | Exact Sciences Corporation | Cologuard Collection Kit (Device) | Food and Beverage | In-kind items and services | $14.09 | General |
| Category: Oncology | ||||||
| 12/04/2024 | Lundbeck LLC | REXULTI (Drug) | Food and Beverage | Cash or cash equivalent | $19.08 | General |
| Category: PSYCHIATRY | ||||||
| 12/02/2024 | Axsome Therapeutics, Inc. | Auvelity (Drug) | Food and Beverage | In-kind items and services | $21.89 | General |
| Category: Psychology/Psychiatric | ||||||
| 11/22/2024 | Lilly USA, LLC | MOUNJARO (Drug), ZEPBOUND | Food and Beverage | In-kind items and services | $17.17 | General |
| Category: Diabetes | ||||||
| 11/21/2024 | Lundbeck LLC | REXULTI (Drug) | Food and Beverage | Cash or cash equivalent | $23.67 | General |
| Category: PSYCHIATRY | ||||||
| 11/21/2024 | Axsome Therapeutics, Inc. | Auvelity (Drug) | Food and Beverage | In-kind items and services | $18.93 | General |
| Category: Psychology/Psychiatric | ||||||
| 11/19/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $18.34 | General |
| Category: Obesity | ||||||
| 11/15/2024 | ABBVIE INC. | QULIPTA (Drug) | Food and Beverage | In-kind items and services | $15.48 | General |
| Category: NEUROSCIENCE | ||||||
| 11/14/2024 | ABBVIE INC. | QULIPTA (Drug), UBRELVY | Food and Beverage | In-kind items and services | $24.72 | General |
| Category: NEUROSCIENCE | ||||||
| 11/12/2024 | PFIZER INC. | PREVNAR 20 (Biological), COMIRNATY, ABRYSVO | Food and Beverage | In-kind items and services | $15.74 | General |
| Category: VACCINES | ||||||
| 11/08/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $14.16 | General |
| Category: DIABETES | ||||||
| 11/06/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $17.84 | General |
| Category: Gastroenterology | ||||||
| 11/05/2024 | Novo Nordisk Inc | — | Food and Beverage | In-kind items and services | $20.51 | General |
| 11/01/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug), AREXVY | Food and Beverage | In-kind items and services | $18.69 | General |
| Category: RESPIRATORY | ||||||
| 10/30/2024 | Abbott Laboratories | FREESTYLE LIBRE 3 (Device) | Food and Beverage | In-kind items and services | $17.86 | General |
| Category: Diabetes Care | ||||||
| 10/28/2024 | ABBVIE INC. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $10.09 | General |
| Category: NEUROSCIENCE | ||||||
| 10/23/2024 | Takeda Pharmaceuticals U.S.A., Inc. | TRINTELLIX (Drug) | Food and Beverage | In-kind items and services | $18.48 | General |
| Category: NEUROSCIENCE | ||||||
| 10/22/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $21.92 | General |
| Category: Obesity | ||||||
| 10/11/2024 | ABBVIE INC. | QULIPTA (Drug) | Food and Beverage | In-kind items and services | $32.82 | General |
| Category: NEUROSCIENCE | ||||||
| 10/10/2024 | Currax Pharmaceuticals LLC | ONZETRA XSAIL (Drug), CONTRAVE | Food and Beverage | In-kind items and services | $15.33 | General |
| Category: Neurology | ||||||
| 10/08/2024 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | CAPLYTA (Drug) | Food and Beverage | In-kind items and services | $21.98 | General |
| Category: PSYCHIATRY | ||||||
| 10/04/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $13.10 | General |
| Category: DIABETES | ||||||
| 10/03/2024 | AstraZeneca Pharmaceuticals LP | — | Food and Beverage | In-kind items and services | $22.12 | General |
| 10/01/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $18.25 | General |
| Category: Diabetes | ||||||
| 09/26/2024 | Lilly USA, LLC | MOUNJARO (Drug), ZEPBOUND | Food and Beverage | In-kind items and services | $15.85 | General |
| Category: Diabetes | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 13 | 953 | 1,754 | $296,725 | $92,613 |
| 2022 | 11 | 717 | 1,367 | $212,006 | $69,205 |
| 2021 | 10 | 515 | 833 | $163,851 | $55,050 |
| 2020 | 10 | 411 | 783 | $105,667 | $27,958 |
All Medicare Procedures & Services
44 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 380 | 873 | $179,838 | $56,534 | 31.4% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 225 | 225 | $73,125 | $23,518 | 32.2% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 116 | 130 | $18,070 | $5,959 | 33.0% |
| G0438 | Annual wellness visit; includes a personalized prevention plan of service (pps), initial visit | Office | 2023 | 17 | 17 | $8,279 | $2,294 | 27.7% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 21 | 21 | $5,817 | $2,062 | 35.4% |
| G0180 | Physician or allowed practitioner certification for medicare-covered home health services under a home health plan of care (patient not present), including contacts with home health agency and review of reports of patient status required by physicians and | Office | 2023 | 17 | 19 | $3,059 | $603.90 | 19.7% |
| G0008 | Administration of influenza virus vaccine | Office | 2023 | 17 | 17 | $1,207 | $492.83 | 40.8% |
| 90686 | Influenza vaccine, quadrivalent, preservative free, 0.5 ml dosage | Office | 2023 | 17 | 17 | $1,003 | $372.30 | 37.1% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2023 | 32 | 48 | $3,408 | $367.67 | 10.8% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2023 | 34 | 34 | $2,040 | $279.13 | 13.7% |
| 81003 | Automated urinalysis test | Office | 2023 | 35 | 40 | $400.00 | $88.00 | 22.0% |
| J0696 | Injection, ceftriaxone sodium, per 250 mg | Office | 2023 | 19 | 83 | $249.00 | $23.35 | 9.4% |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | Office | 2023 | 23 | 230 | $230.00 | $19.66 | 8.5% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 380 | 761 | $156,766 | $52,192 | 33.3% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2022 | 62 | 62 | $20,150 | $6,638 | 32.9% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 76 | 81 | $11,259 | $3,972 | 35.3% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 28 | 29 | $8,033 | $3,100 | 38.6% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 29 | 29 | $9,251 | $2,052 | 22.2% |
| G0008 | Administration of influenza virus vaccine | Office | 2022 | 14 | 14 | $994.00 | $382.48 | 38.5% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2022 | 29 | 39 | $2,769 | $296.82 | 10.7% |
| 90686 | Influenza vaccine, quadrivalent, preservative free, 0.5 ml dosage | Office | 2022 | 14 | 14 | $826.00 | $295.26 | 35.7% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2022 | 18 | 18 | $1,080 | $140.37 | 13.0% |
| 81003 | Automated urinalysis test | Office | 2022 | 43 | 52 | $520.00 | $115.13 | 22.1% |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | Office | 2022 | 24 | 268 | $358.00 | $21.25 | 5.9% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 222 | 520 | $107,120 | $36,393 | 34.0% |
About Willard Beard, PA-C
Willard Beard, PA-C is a Physician Assistant healthcare provider based in Pineville, Louisiana. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 10/09/2008. The National Provider Identifier (NPI) number assigned to this provider is 1598916330.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Willard Beard, PA-C has received a total of $5,546 in payments from pharmaceutical and medical device companies, with $1,652 received in 2024. These payments were reported across 353 transactions from 29 companies. The most common payment nature is "Food and Beverage" ($5,546).
As a Medicare-enrolled provider, Beard has provided services to 2,596 Medicare beneficiaries, totaling 4,737 services with total Medicare billing of $244,826. Data is available for 4 years (2020–2023), covering 44 distinct procedure/service records.
Practice Information
- Specialty Physician Assistant
- Location Pineville, LA
- Active Since 10/09/2008
- Last Updated 02/10/2022
- Taxonomy Code 363A00000X
- Entity Type Individual
- NPI Number 1598916330
Products in Payments
- QULIPTA (Drug) $813.79
- UBRELVY (Drug) $564.35
- TRINTELLIX (Drug) $538.05
- Wegovy (Drug) $303.91
- JARDIANCE (Drug) $277.74
- NURTEC ODT (Drug) $234.75
- MOUNJARO (Drug) $218.31
- Rybelsus (Drug) $209.64
- TRELEGY ELLIPTA (Drug) $200.48
- Ozempic (Drug) $185.37
- TRULICITY (Drug) $180.53
- VRAYLAR (Drug) $180.35
- FARXIGA (Drug) $147.89
- REXULTI (Drug) $134.18
- XIFAXAN (Drug) $84.62
- LINZESS (Drug) $78.94
- EMGALITY (Drug) $75.36
- FREESTYLE LIBRE 3 (Device) $72.38
- AREXVY (Drug) $64.48
- SYNTHROID (Drug) $61.82
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Physician Assistant Doctors in Pineville
Tony Connot, Pa-C, PA-C
Physician Assistant — Payments: $1,861
Mr. Brian Bowman, Pa-C, PA-C
Physician Assistant — Payments: $1,272
Benjamin Mccurdy, Pa, PA
Physician Assistant — Payments: $1,143
Taylor Price, Pa-C, PA-C
Physician Assistant — Payments: $653.74
Mallorie Parham, Pa-C, PA-C
Physician Assistant — Payments: $551.23
Greta Grant, Pa-C, PA-C
Physician Assistant — Payments: $477.09